MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer


Eralp Y., Derin D., Ozluk Y. , Yavuz E., Guney N., Saip P., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.19, sa.4, ss.669-674, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Konu: 4
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1093/annonc/mdm522
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Sayfa Sayıları: ss.669-674

Özet

Background: Triple-negative breast cancer is estimated to account for 15%-20% of all patients with breast cancer and is considered as a prognostically unfavorable subset. The aim of this study is to evaluate the prognostic impact of various molecular factors in patients with triple-negative breast cancer.